What Can IBD Specialists Learn from IL-23 Trials in Dermatology?

BACKGROUND AND AIMS: The advent of biologic drugs revolutionised the treatment of many chronic inflammatory diseases in rheumatology, dermatology, and gastroenterology. The introduction of different targeted agents closely followed the increase in knowledge of pathogenic mechanisms. The identificati...

Descripción completa

Detalles Bibliográficos
Autores principales: Valenti, Mario, Narcisi, Alessandra, Pavia, Giulia, Gargiulo, Luigi, Costanzo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097670/
https://www.ncbi.nlm.nih.gov/pubmed/35553663
http://dx.doi.org/10.1093/ecco-jcc/jjac023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097670/
https://www.ncbi.nlm.nih.gov/pubmed/35553663
http://dx.doi.org/10.1093/ecco-jcc/jjac023

Ejemplares similares